mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.3 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.3 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |